LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Pipeline
Deals
Financings
Articles
Jsr Corp.
Headquarters:
Tokyo, Japan
Website:
http://www.jsr.co.jp/jsr_e/
Year Founded:
1957
Status:
Private
BioCentury
|
Jul 22, 2021
Deals
July 21 Quick Takes: Turnstone’s $80M round to advance oncolytic virus, TIL programs
Plus: Vedanta, bluebird, Cytokinetics and more
Read More
BioCentury
|
Nov 7, 2020
Finance
Apollomics anchors investor base in Asia with $124M raise as it readies for its next phase of growth
Ping An Capital leads series C round for cross-border cancer in-licensing play
Read More
BioCentury
|
Jan 10, 2020
Company News
Management tracks: COO, CMO depart as Solid restructures; plus Abeona, Millendo, Immuneering, Akouos, Kintai, Macrophage, Selexis, Prime
Read More
BioCentury
|
Jan 9, 2020
Financial News
Aspect to engineer therapeutic tissues with $20M series A
Read More
BioCentury
|
Jun 14, 2019
Preclinical News
June 13 Preclinical Quick Takes: A*STAR's mAb against tumor-displayed antigen; plus Columbia, Genentech and more
Read More
BioCentury
|
Jun 11, 2019
Company News
June 11 Company Quick Takes: Genmab, Janssen together again on CD38; plus GT Apeiron’s launch; BiomX, Aimmune, Keytruda
Read More
BioCentury
|
Feb 25, 2019
Company News
Management tracks: Viriom, Matinas, Atreca
Read More
BioCentury
|
Jan 11, 2019
Financial News
CBT rebrands as Apollomics, raises $100M series B
Read More
BioCentury
|
Jan 7, 2019
Financial News
CBT rebrands as Apollomics, raises $100M series B
Read More
BioCentury
|
Feb 9, 2018
Product R&D
Debugging the microbiome
How BiomX is using bacteriophages to modulate the microbiome
Read More
Items per page:
10
1 - 10 of 18